| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $111.0M | -2.5% |
| R&D Expense | $3.5M | -59.0% |
| SG&A Expense | $15.3M | -7.4% |
| Operating Income | -$11.2M | +6.0% |
| Pre-tax Income | -$7.5M | +29.3% |
| Income Tax | -$131K | -131.1% |
| Net Income | -$7.4M | +33.2% |
| EPS (Basic) | -$0.38 | +33.3% |
| EPS (Diluted) | -$0.38 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $69.9M | +38.2% |
| Accounts Receivable | $25.0M | +15.8% |
| Inventory | $14.9M | -35.3% |
| Current Assets | $117.8M | -3.9% |
| Total Assets | $151.5M | -2.3% |
| Current Liabilities | $16.7M | +5.0% |
| Total Liabilities | $20.5M | +24.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $17.1M | +229.9% |
| Capital Expenditures | $7.4M | -0.8% |
| Investing Cash Flow | $3.9M | -92.6% |
| Financing Cash Flow | -$1.7M | -1639.1% |
| Free Cash Flow | $9.8M | +147.4% |
| +33.3% |
| Stockholders' Equity |
| $131.0M |
| -5.5% |